Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults.
Ribera E, Lopez RM, Diaz M, Pou L, Ruiz L, Falcó V, Crespo M, Azuaje C, Ruiz I, Ocaña I, Clotet B, Pahissa A. Ribera E, et al. Among authors: azuaje c. Antimicrob Agents Chemother. 2004 Nov;48(11):4256-62. doi: 10.1128/AAC.48.11.4256-4262.2004. Antimicrob Agents Chemother. 2004. PMID: 15504850 Free PMC article. Clinical Trial.
Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study).
Ribera E, Azuaje C, Lopez RM, Domingo P, Soriano A, Pou L, Sánchez P, Mallolas J, Sambea MA, Falco V, Ocaña I, Lopez-Colomes JL, Gatell JM, Pahissa A. Ribera E, et al. Among authors: azuaje c. J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):317-23. doi: 10.1097/01.qai.0000182629.74336.4d. J Acquir Immune Defic Syndr. 2005. PMID: 16249706 Clinical Trial.
Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
Ribera E, Azuaje C, Lopez RM, Domingo P, Curran A, Feijoo M, Pou L, Sánchez P, Sambeat MA, Colomer J, Lopez-Colomes JL, Crespo M, Falcó V, Ocaña I, Pahissa A. Ribera E, et al. Among authors: azuaje c. J Antimicrob Chemother. 2007 Apr;59(4):690-7. doi: 10.1093/jac/dkl552. Epub 2007 Feb 16. J Antimicrob Chemother. 2007. PMID: 17307771
Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.
López P, Gavaldà J, Martin MT, Almirante B, Gomis X, Azuaje C, Borrell N, Pou L, Falcó V, Pigrau C, Pahissa A. López P, et al. Among authors: azuaje c. Antimicrob Agents Chemother. 2001 May;45(5):1387-93. doi: 10.1128/AAC.45.5.1387-1393.2001. Antimicrob Agents Chemother. 2001. PMID: 11302800 Free PMC article.
Health-related quality of life in HIV-infected naive patients treated with nelfinavir or nevirapine associated with ZDV/3TC (the COMBINE-QoL substudy).
Casado A, Badia X, Consiglio E, Ferrer E, González A, Pedrol E, Gatell JM, Azuaje C, Llibre JM, Aranda M, Barrufet P, Martínez-Lacasa J, Podzamczer D; COMBINE Study Team. Casado A, et al. Among authors: azuaje c. HIV Clin Trials. 2004 May-Jun;5(3):132-9. doi: 10.1310/EACX-1RFX-41R5-VH45. HIV Clin Trials. 2004. PMID: 15248137 Clinical Trial.
13 results